A
A.1 - Enzymatic inhibitions easily translate into whole-cell activities.
B
B.2 - Phenotypic-based approaches mostly afford compounds that are not specifically toxic to bacteria.
C
C.3 - Screening collections are well suited to discover antibacterial hits.
